TY  - GEN
AU  - Collins,P W
AU  - Quon,D V K
AU  - Makris,M
AU  - Chowdary,P
AU  - Kempton,C L
AU  - Apte,S J
AU  - Ramanan,M V
AU  - Hay,C R M
AU  - Drobic,B
AU  - Hua,Y
AU  - Babinchak,T J
AU  - Gomperts,E D
TI  - Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients
SN  - 1365-2516
PY  - 2018///0725
KW  - Adolescent
KW  - Adult
KW  - Area Under Curve
KW  - Blood Coagulation Factor Inhibitors
KW  - blood
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Factor IX
KW  - adverse effects
KW  - Half-Life
KW  - Headache
KW  - etiology
KW  - Hemophilia B
KW  - drug therapy
KW  - Hemorrhage
KW  - prevention & control
KW  - Humans
KW  - Male
KW  - ROC Curve
KW  - Recombinant Proteins
KW  - pharmacokinetics
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1111/hae.13324
ER  -